Enable Injections Archives - Medical Design Sourcing

Enable Injections to expand manufacturing facility to support drug delivery device production

The Empaveli Injector. [Image courtesy of Enable Injections/Apellis Pharma]Enable Injections announced today that it plans to expand its manufacturing operations with a new, large-scale facility in Ohio.

In addition to the expansion in Springdale, Ohio, the company plans to enhance its corporate headquarters in Evendale, Ohio. Both facilities, nearby one another, sit just outside of Cincinnati.

Enable Injections plans for its new 90,000-square-foot manufacturing center to support ongoing in-house manufacturing and supply of its enFuse medicine delivery technology. The company develops the enFuse platform, which allows hands-free, hidden needle drug delivery of up to 25 mL. Its simple design enables flexibility for at-home self-administration or in-clinic use.

The FDA cleared the system for the delivery of Empaveli in October. Enable Injections says it’s the first-ever hands-free wearable technology that allows patients to self-administer large-volume …

Enable Injections promotes COO from within

David Kroekel. [Image courtesy of Enable Injections]Wearable drug delivery technology maker Enable Injections announced today that it named David Kroekel as its new COO.

Cincinnati-based Enable develops the enFuse platform, whichallows hands-free, hidden needle drug delivery of up to 25 mL. Its simple design enables flexibility for at-home self-administration or in-clinic use. The FDA cleared the system for the delivery of Empaveli in October.

Get the full story at our sister site, Drug Delivery Business News.

Enable Injections adds finance veteran to its board

New Enable Injections board member Vickie Capps. [Image from NuVasive]Enable Injections announced today that it appointed Vickie Capps to its board of directors as the head of the audit committee.

Capps joins the wearable drug delivery system maker with plenty of experience in finance and executive leadership. She also brings extensive board experience, including currently serving on the board of orthopedic company NuVasive.

Other boards Capps serves on include Amedisys and Janux Therapeutics. She serves as a member of the senior advisory board at Consonance Capital Partners, a healthcare-focused private equity firm. Her record includes serving as CFO of DJO Global from 2002 to 2013 as well.

Capps joins the board of Enable Injections at a good time. The company just picked up FDA approval for its enFuse injector for the delivery of Empaveli.

Get the full story at our sister site, Drug Delivery Business News.

FDA approves wearable injector from Enable Injections

The Empaveli Injector. [Image courtesy of Enable Injections/Apellis Pharma]Enable Injections announced today that it received FDA approval for its enFuse injector for the delivery of Empaveli.

Empaveli, commercialized by Apellis Pharmaceuticals, treats adults with paroxysmal nocturnal hemoglobinuria (PNH). The injector — in this case, called the Empaveli Injector — offers self-administration of the pharmaceutical. The compact, wearable device streamlines the self-administration experience with minimal disruption to daily lives.

Get the full story at our sister site, Drug Delivery Business News.

The biggest medical device VC deals of 2022

Enable Injections, which makes the enFuse device, raised $215 million in January 2022. [Photo courtesy of Enable Injections]

Last year was definitely a slower year for medical device VC deals than the year before.

Biofourmis was the only medical device developer in the 10 largest healthcare VC deals of 2022, according to a ranking provided to Medical Design & Outsourcing by Silicon Valley Bank (SVB).

Because we love devices at Medical Design & Outsourcing, we asked SVB for a ranking of 2022’s largest medical device VC deals after Biofourmis, which raised $325 million in its 2022 series D round. (The year before that, CMR Surgical’s $600 million Series D financing round was the largest medical device VC deal of 2021.)

SVB obliged, once again drawing upon its own proprietary information and data from Pitchbook. The dealmakers include device developers with innovative methods for …

8 drug delivery innovations you need to know

The drug delivery space has seen plenty of innovation over the years and there are no signs of that slowing down any time soon.

Improvements upon established technologies like insulin delivery devices and inhalers have been presented by some, while others have unlocked new ways of delivering drugs through a variety of means.

Among the best innovations in the space are some of the heavy-hitting companies, like Medtronic and Tandem Diabetes Care. Some up-and-comers are beginning to make waves, too, while research continues to uncover new ways to deliver therapeutics.

Here are eight types of drug delivery innovations you should know:

Next>>

8 drug delivery innovations you need to know

The drug delivery space has seen plenty of innovation over the years and there are no signs of that slowing down any time soon.

Improvements upon established technologies like insulin delivery devices and inhalers have been presented by some, while others have unlocked new ways of delivering drugs through a variety of means.

Among the best innovations in the space are some of the heavy-hitting companies, like Medtronic and Tandem Diabetes Care. Some up-and-comers are beginning to make waves, too, while research continues to uncover new ways to deliver therapeutics.

Here are eight types of drug delivery innovations you should know:

Next>>

Enable Injections completes $25M credit facility

Enable Injections announced today that it completed a credit facility worth $25 million from Oxford Finance LLC.

Cincinnati-based Enable Injections said in a news release that the funds are earmarked for supporting the scaling of high-volume manufacturing and the achievement of major inflection points as it moves toward commercialization.

Get the full story at our sister site, Drug Delivery Business News.